Dr. Tess Bittermann is a transplant hepatologist and epidemiologist. She recently transitioned from the University of Pennsylvania in Philadelphia to a joint position at the Royal Brisbane and Women's Hospital and the Queensland Institute for Medical Research in Brisbane, Australia. Her research focuses on the practice heterogeneity and understanding the comparative risks and benefits of immunosuppression strategies among transplant recipients and patients with autoimmune hepatitis.

Cristal Brown, MD, MHS is a transplant hepatologist and Assistant Professor of Medicine at the University of Texas at Austin Dell Medical School. As a physician-scientist, Dr. Brown focuses on interventions to help eliminate health disparities throughout the trajectory of end-stage liver disease.

Dr. Adnan Said is a Professor in the Division of Gastroenterology and Hepatology within the Department of Medicine at the University of Wisconsin (UW) School of Medicine and Public Health in Madison, WI. He also serves as program director of the UW Health Transplant hepatology Fellowship, Director of the UW Health Metabolic Liver Clinic and as Medical Director of the VA Liver Transplant Program.Dr.

Director, The Autoimmune and Rare Liver Disease Programme, and the Lily and Terry Horner Chair in Autoimmune Liver Disease Research, Division of Gastroenterology and Hepatology, Toronto General Hospital, Canada

Dr. Mazumder's research centers on predicting outcome for patients with liver disease. Specifically, his interest is in the interplay between the pathophysiology of portal hypertension and the cardio-renal axis as it applies to personalizing care for patients. He is interested in mathematical modeling, biosignals, markers of volume status, and machine learning.

Dr. Heather Patton is a Transplant Hepatologist and the Section Chief of Gastroenterology for the VA San Diego Healthcare System. She currently serves as the Chair of the Hepatology Field Advisory Board to the VHA National Gastroenterology and Hepatology Program Office. In this capacity, she works with subcommittees addressing steatotic liver disease, cirrhosis, and hepatocellular carcinoma to serve as subject matter experts, develop policy, and represent the interests of VA specialty providers in the care of veterans with liver disease.

Associate Professor of Medicine in the Section of Digestive Diseases, Yale School of Medicine.<br>Clinical and research interest in autoimmune and cholestatic liver diseases. Associate Director of the Clinical and Translational Core of the Yale Liver Center.<br>GI fellowship Program Director.

Monika Sarkar is a Professor of Hepatology/Liver Transplant at UCSF where she runs the UCSF Women's Liver Program and multidisciplinary liver disease in pregnancy clinic. Her clinical and NIH-funded research program is focused on reproductive health in liver disease, with particular interest in MASLD and autoimmune liver disease, She is former chair of the AASLD Women's Committee, and current chair of the AST Women's Health Community of Practice. She currently serves on the AASLD Nominations Committee.

Dr. Civan is a transplant hepatologist at Thomas Jefferson University in Philadelphia. He has clinical and research interests in hepatocellular carcinoma.